We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
-12.52%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$6.47B
AUM Growth
-$1.7B
Cap. Flow
-$612M
Cap. Flow %
-9.46%
Top 10 Hldgs %
39.4%
Holding
758
New
244
Increased
84
Reduced
79
Closed
303

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$69.4M
2
MS icon
Morgan Stanley
MS
+$50.7M
3
C icon
Citigroup
C
+$50.1M
4
AMZN icon
Amazon
AMZN
+$49.8M
5
WBD icon
Warner Bros
WBD
+$42.6M

Top Sells

Rank Stock Value
1
IFF icon
International Flavors & Fragrances
IFF
+$284M
2
TMUS icon
T-Mobile US
TMUS
+$161M
3
QCOM icon
Qualcomm
QCOM
+$151M
4
MU icon
Micron Technology
MU
+$149M
5
BABA icon
Alibaba
BABA
+$144M

Sector Composition

Rank Sector Weight
1 Healthcare 11.55%
2 Communication Services 6.92%
3 Consumer Discretionary 5.57%
4 Utilities 3.44%
5 Financials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSCO icon
201
Tractor Supply
TSCO
$18B
$2.97M 0.05%
+76,680
New +$3.12M
ADI icon
202
PUT
Analog Devices
ADI
$187B
$2.97M 0.05%
+20,300
New +$3.2M
WFC icon
203
Wells Fargo
WFC
$265B
$2.89M 0.04%
73,696
-148,904
-67% -$6.53M
WVE icon
204
Wave Life Sciences
WVE
$1.2B
$2.83M 0.04%
+871,500
New +$1.68M
META icon
205
Meta Platforms (Facebook)
META
$1.52T
$2.79M 0.04%
17,316
+16,916
+4,229% +$3.26M
ZBH icon
206
Zimmer Biomet
ZBH
$18.7B
$2.78M 0.04%
+26,499
New +$3.14M
VIRX
207
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.71M 0.04%
+698,000
New +$1.99M
ZVRA icon
208
Zevra Therapeutics
ZVRA
$682M
$2.6M 0.04%
+582,261
New +$2.65M
YUMC icon
209
Yum China
YUMC
$16.5B
$2.59M 0.04%
+53,382
New +$2.25M
CRWD icon
210
CALL
CrowdStrike
CRWD
$229B
$2.53M 0.04%
+60,000
New +$2.72M
CRWD icon
211
PUT
CrowdStrike
CRWD
$229B
$2.53M 0.04%
+60,000
New +$2.72M
VMW
212
DELISTED
VMware, Inc
VMW
$2.46M 0.04%
21,587
-18,068
-46% -$2.05M
PANW icon
213
Palo Alto Networks
PANW
$314B
$2.45M 0.04%
29,802
+4,200
+16% +$372K
ATOS icon
214
Atossa Therapeutics
ATOS
$23.7M
$2.43M 0.04%
+148,387
New +$2.34M
BSX icon
215
Boston Scientific
BSX
$73.1B
$2.41M 0.04%
64,781
+56,416
+674% +$2.3M
EXPE icon
216
Expedia Group
EXPE
$37.7B
$2.35M 0.04%
+24,799
New +$3.51M
IMA
217
ImageneBio Inc
IMA
$64.9M
$2.34M 0.04%
+44,083
New +$2.43M
AZN icon
218
AstraZeneca
AZN
$251B
$2.33M 0.04%
+17,613
New +$2.31M
CTMX icon
219
CytomX Therapeutics
CTMX
$750M
$2.33M 0.04%
+1,270,900
New +$2.43M
MET icon
220
MetLife
MET
$61.7B
$2.31M 0.04%
+36,842
New +$2.44M
HR icon
221
Healthcare Realty
HR
$6.73B
$2.3M 0.04%
+84,459
New +$2.51M
AMGN icon
222
Amgen
AMGN
$226B
$2.24M 0.03%
+9,221
New +$2.26M
ORCL icon
223
CALL
Oracle
ORCL
$435B
$2.22M 0.03%
31,800
-82,400
-72% -$6.03M
HOWL icon
224
Werewolf Therapeutics
HOWL
$18.6M
$2.19M 0.03%
+535,160
New +$2.44M
IHS icon
225
IHS Holding
IHS
$2.79B
$2.17M 0.03%
208,247
-73,159
-26% -$813K
7 8
9
10 11

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

Laurion Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Laurion Capital Management held 758 positions worth $6.47B, down 21% from $8.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Laurion Capital Management withdrew a net $612M in Q2 2022, closing 303 positions and reducing 79 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $284M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Laurion Capital Management opened a new position in Morgan Stanley worth $47M.

  • Laurion Capital Management's largest Q2 2022 buy was Morgan Stanley: 618,580 shares worth $47M.
  • Laurion Capital Management added most to Lowe's Companies in Q2 2022, an estimated $69.4M increase.
  • Laurion Capital Management's biggest Q2 2022 reduction was T-Mobile US, cutting an estimated $161M.
  • Laurion Capital Management fully exited International Flavors & Fragrances in Q2 2022, selling an estimated $284M.
  • Laurion Capital Management's ten largest holdings make up 39% of its $6.47B portfolio in Q2 2022.
  • Laurion Capital Management opened 244 new positions and closed 303 in Q2 2022.
  • Laurion Capital Management's portfolio value fell 21% quarter-over-quarter to $6.47B.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.